The increased FGF-21 and reduced adiponectin level, along with oxidative stress and inflammation in vitamin D-deficient newly diagnosed T2DM subjects, could further increase the cardiovascular disease risk in them. Here, ADIPOQ is linked to cardiovascular disorder.